{
    "title": "115_s2260",
    "content": "The Act may be cited as the \"Opioids and STOP Pain Initiative Act\" and establishes the initiative. The Opioids and STOP Pain Initiative, administered by the Director of the National Institutes of Health, supports research on understanding pain, developing therapies for chronic pain, and finding alternatives to opioids. It also focuses on improving medication-assisted treatment options. The Federal Pain Research Strategy aims to develop novel drugs and non-pharmacological treatments for pain, improve care delivery models, and utilize precision medicine to prevent and treat pain. It also includes components of the Department of Health and Human Services five-point strategy to address the opioid crisis through cutting-edge research on pain. The Federal Pain Research Strategy focuses on developing new treatments for pain, improving care delivery models, and utilizing precision medicine. It includes a pain therapy screening program and other designated elements by the Secretary of Health and Human Services in consultation with the Director of the National Institutes of Health. SEC. 3. FUNDING FOR THE OPIOIDS AND STOP PAIN INITIATIVE. $5 billion is appropriated to the National Institutes of Health Innovation Account over a 5-year period for the Opioids and STOP Pain Initiative. The funds are designated as an emergency requirement. SEC. 4. PAIN THERAPY SCREENING PROGRAM. The Pain Therapy Screening Program, overseen by the Secretary of Health and Human Services, focuses on developing pain therapeutics. Grants are awarded to support the creation of new pre-clinical models for pain disorders. The program is based on the Epilepsy Therapy Screening Program. Fees may be charged to private pharmaceutical or medical device industry entities using the program for screening. The Pain Therapy Screening Program overseen by the Secretary of Health and Human Services focuses on developing pain therapeutics. Fees charged to entities using the program are paid to the Foundation for the National Institutes of Health for the Opioids and STOP Pain Initiative. The Director of the National Institutes of Health determines and allocates funds for the program. The funding provisions for the Pain Therapy Screening Program overseen by the Secretary of Health and Human Services are determined and allocated by the Director of the National Institutes of Health. The Secretary of Health and Human Services may accept donations for pain and opioid research programs. Donations will be transferred to the NIH Innovation Account for the Opioids and STOP Pain Initiative. Contributions may be included in basic research for research credit. The National Institutes of Health can receive donations for the Opioids and STOP Pain Initiative, which can be used for research credit. Amendments to the Internal Revenue Code of 1986 allow for this initiative to be supported, effective for taxable years after the enactment of the Act. The Director of the National Institutes of Health can use funds for research under the Opioids and STOP Pain Initiative. They may enter into transactions to carry out the identified research. Additionally, reports are required to be submitted. The Director of the National Institutes of Health must submit annual reports to specified committees detailing funds spent on programs, activities, and their impact on public health, including pain treatment. The Director of the National Institutes of Health will provide updates to relevant committees upon request regarding funding allocation and program descriptions under the Act."
}